Category Specific RSS

News

Theta Gold Mines ups production plans with purchase of mill

With gold prices still sitting at lofty heights, Theta Gold Mines (ASX: TGM) has taken a major step forward in their South African gold operations with the AUD $550,000 purchase of a ball mill. 

The secondhand mill was previously used by Glencore with independent expectations confirming the mill to be in excellent condition. The purchase enables Theta to expedite production operations at a time when market conditions are highly favourable for gold producers. 

“An equivalent new 2.5MW ball mill with spare parts costs ~A$5.5m and would take up to 40 weeks from order to delivery,” said Chairman, Bill Guy. 

“Instead, Theta has managed to secure a secondhand mill in excellent condition, and with an inventory of vital spare parts for less than A$800,000 (incl. dissemble & delivery), and pleasingly, it can be relocated to the TGME Processing plant by January 2020. 

“The purchase also provides certainty of grinding capability for the mine and, being larger than initially planned for in the feasibility study, allows for future throughput increases. Securing this ball mill marks another key milestone towards first production.”

With the Ball Mill being located at Rustenberg, South Africa, the Company anticipates relocation of the mill to their Pilgrims Rest project by January 2020. 

Within Pilgrims Rest, Theta has a significant gold resource in the historically high yielding region, where their combination of JORC-compliant prospects combine for approximately 6 million ounces of gold (44.8Mt @ 4.18g/t Au).

Their three major goldfields are located 370km NE of Johannesburg where the fields have produced more than 6.7Moz of gold since 1880. 

Gold prices have been rising notably since September 2018 when the price of Gold was US$1180 per ounce and now trade at around $1500 a year later. This has significantly increased gold project valuations whilst reducing project payback periods for gold developers advancing to production.

Theta’s project feasibility study completed in May 2019, identified the Project to have Post‐tax NPV5% of USD49.6m and 65.1% IRR. 

The Company recently completed an $8m capital raise to advance production facilities with those shares to be held in escrow until December 2020. 

 

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

2 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago